Review article · 2024 · Open access

Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy

Yue Song, Qing‐Qing Dong, Yi-Ke Ni, Xiaoling Xu, Chao-Xiang Chen, Wei Chen

International Journal of Nanomedicine, Volume 19, 5739–5761 · Published 1 June 2024 · DOI 10.2147/ijn.s448684

Open PDFView at the publisherCite this paper

In brief

“Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy” is a 2024 review article by Yue Song and 5 co-authors, published in International Journal of Nanomedicine. OpenAlex counts 51 citations as of 22 November 2026, which puts it in the top 7% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at International Journal of Nanomedicine.

Citations
51
Most cited in
2026 (28)
Field-weighted impact
1.65
References
137
Authors
6

Abstract

Proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules that have the capability to induce specific protein degradation. While playing a revolutionary role in effectively degrading the protein of interest (POI), PROTACs encounter certain limitations that impede their clinical translation. These limitations encompass off-target effects, inadequate cell membrane permeability, and the hook effect. The advent of nanotechnology presents a promising avenue to surmount the challenges associated with conventional PROTACs. The utilization of nano-proteolysis targeting chimeras (nano-PROTACs) holds the potential to enhance specific tissue accumulation, augment membrane permeability, and enable controlled release. Consequently, this approach has the capacity to significantly enhance the controllable degradation of target proteins. Additionally, they enable a synergistic effect by combining with other therapeutic strategies. This review comprehensively summarizes the structural basis, advantages, and limitations of PROTACs. Furthermore, it highlights the latest advancements in nanosystems engineered for delivering PROTACs, as well as the development of nano-sized PROTACs employing nanocarriers as linkers. Moreover, it delves into the underlying principles of nanotechnology tailored specifically for PROTACs, alongside the current prospects of clinical research. In conclusion, the integration of nanotechnology into PROTACs harbors vast potential in enhancing the anti-tumor treatment response and expediting clinical translation.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Song, Y., Dong, Q., Ni, Y.-K., Xu, X., Chen, C.-X., & Chen, W. (2024). Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy. International Journal of Nanomedicine, Volume 19, 5739–5761. https://doi.org/10.2147/ijn.s448684

MLA 9

Song, Yue, et al. “Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy.” International Journal of Nanomedicine, vol. Volume 19, 2024, pp. 5739–5761. https://doi.org/10.2147/ijn.s448684.

Chicago

Song, Yue, Qing‐Qing Dong, Yi-Ke Ni, Xiaoling Xu, Chao-Xiang Chen, and Wei Chen. 2024. “Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy.” International Journal of Nanomedicine Volume 19: 5739–5761. https://doi.org/10.2147/ijn.s448684.

Harvard

Song, Y. et al. (2024) ‘Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy’, International Journal of Nanomedicine, Volume 19, pp. 5739–5761. doi:10.2147/ijn.s448684.

IEEE

Y. Song, Q. Dong, Y.-K. Ni, X. Xu, C.-X. Chen, and W. Chen, “Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy,” International Journal of Nanomedicine, vol. Volume 19, pp. 5739–5761, 2024, doi: 10.2147/ijn.s448684.

BibTeX

@article{song2024nano,
  title     = {{Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy}},
  author    = {Song, Yue and Dong, Qing‐Qing and Ni, Yi-Ke and Xu, Xiaoling and Chen, Chao-Xiang and Chen, Wei},
  journal   = {International Journal of Nanomedicine},
  year      = {2024},
  volume    = {Volume 19},
  pages     = {5739--5761},
  doi       = {10.2147/ijn.s448684},
  url       = {https://doi.org/10.2147/ijn.s448684}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202422
20252121
20262828

Its field-weighted citation impact is 1.65: it has been cited 1.65 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • targeted protein degradation
  • nanocarriers
  • nanosystems
  • drug delivery
  • membrane permeability
  • hook effect
  • off-target effects

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Song, Y., Dong, Q., Ni, Y.-K., Xu, X., Chen, C.-X., & Chen, W. (2024). Nano-Proteolysis Targeting Chimeras (Nano-PROTACs) in Cancer Therapy. International Journal of Nanomedicine, Volume 19, 5739–5761. https://doi.org/10.2147/ijn.s448684

How many times has this paper been cited?

51 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at International Journal of Nanomedicine: sign in and open the PDF from this page.

Who wrote this paper?

Yue Song, Qing‐Qing Dong, Yi-Ke Ni, Xiaoling Xu, Chao-Xiang Chen, Wei Chen.

What is the DOI of this paper?

10.2147/ijn.s448684, permanently at https://doi.org/10.2147/ijn.s448684. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.